Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Central Nervous System Neoplasms × ONC206 × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 1 Ependymoma 1 Central Nervous System Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 4 Biopsy 3 X-Rays 2 Specimen Handling 2 Phantoms, Imaging 2 Nuclear Medicine Department, Hospital 2 regorafenib 1 pembrolizumab 1 erdafitinib 1 ensartinib 1 cabozantinib 1 alectinib 1 aflibercept 1 Surveys and Questionnaires 1 Radiotherapy 1 Radiation 1 Paclitaxel 1 ONC206 1 Nivolumab 1 NEO212 1 Lomustine 1 Ipilimumab 1 IFL protocol 1 Gadolinium 1 Ferrosoferric Oxide 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04732065 2026-03-17

PNOC023

University of California, San Francisco

Phase 1 Recruiting

Ependymoma, Glioblastoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡